199 related articles for article (PubMed ID: 27084067)
1. Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.
Ghani M; Sato C; Kakhki EG; Gibbs JR; Traynor B; St George-Hyslop P; Rogaeva E
Neurobiol Aging; 2016 Jun; 42():217.e7-217.e13. PubMed ID: 27084067
[TBL] [Abstract][Full Text] [Related]
2. The
Deming Y; Filipello F; Cignarella F; Cantoni C; Hsu S; Mikesell R; Li Z; Del-Aguila JL; Dube U; Farias FG; Bradley J; Budde J; Ibanez L; Fernandez MV; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleo A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Ewers M; Harari O; Haass C; Brett TJ; Benitez BA; Karch CM; Piccio L; Cruchaga C
Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413141
[TBL] [Abstract][Full Text] [Related]
3. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
Carrasquillo MM; Allen M; Burgess JD; Wang X; Strickland SL; Aryal S; Siuda J; Kachadoorian ML; Medway C; Younkin CS; Nair A; Wang C; Chanana P; Serie D; Nguyen T; Lincoln S; Malphrus KG; Morgan K; Golde TE; Price ND; White CC; De Jager PL; Bennett DA; Asmann YW; Crook JE; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N
Alzheimers Dement; 2017 Jun; 13(6):663-673. PubMed ID: 27939925
[TBL] [Abstract][Full Text] [Related]
4. Missense variant in TREML2 protects against Alzheimer's disease.
Benitez BA; Jin SC; Guerreiro R; Graham R; Lord J; Harold D; Sims R; Lambert JC; Gibbs JR; Bras J; Sassi C; Harari O; Bertelsen S; Lupton MK; Powell J; Bellenguez C; Brown K; Medway C; Haddick PC; van der Brug MP; Bhangale T; Ortmann W; Behrens T; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Haines JL; Turton J; Braae A; Barber I; Fagan AM; Holtzman DM; Morris JC; ; ; ; ; ; Williams J; Kauwe JS; Amouyel P; Morgan K; Singleton A; Hardy J; Goate AM; Cruchaga C
Neurobiol Aging; 2014 Jun; 35(6):1510.e19-26. PubMed ID: 24439484
[TBL] [Abstract][Full Text] [Related]
5. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
6. Coding variants in TREM2 increase risk for Alzheimer's disease.
Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
[TBL] [Abstract][Full Text] [Related]
7. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
Wang L; Nykänen NP; Western D; Gorijala P; Timsina J; Li F; Wang Z; Ali M; Yang C; Liu M; Brock W; Marquié M; Boada M; Alvarez I; Aguilar M; Pastor P; Ruiz A; Puerta R; Orellana A; Rutledge J; Oh H; Greicius MD; Le Guen Y; Perrin RJ; Wyss-Coray T; Jefferson A; Hohman TJ; Graff-Radford N; Mori H; Goate A; Levin J; Sung YJ; Cruchaga C
Mol Neurodegener; 2024 Jan; 19(1):1. PubMed ID: 38172904
[TBL] [Abstract][Full Text] [Related]
8. Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population.
Miyashita A; Wen Y; Kitamura N; Matsubara E; Kawarabayashi T; Shoji M; Tomita N; Furukawa K; Arai H; Asada T; Harigaya Y; Ikeda M; Amari M; Hanyu H; Higuchi S; Nishizawa M; Suga M; Kawase Y; Akatsu H; Imagawa M; Hamaguchi T; Yamada M; Morihara T; Takeda M; Takao T; Nakata K; Sasaki K; Watanabe K; Nakashima K; Urakami K; Ooya T; Takahashi M; Yuzuriha T; Serikawa K; Yoshimoto S; Nakagawa R; Saito Y; Hatsuta H; Murayama S; Kakita A; Takahashi H; Yamaguchi H; Akazawa K; Kanazawa I; Ihara Y; Ikeuchi T; Kuwano R
J Alzheimers Dis; 2014; 41(4):1031-8. PubMed ID: 24762945
[TBL] [Abstract][Full Text] [Related]
9. Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.
Patel D; Mez J; Vardarajan BN; Staley L; Chung J; Zhang X; Farrell JJ; Rynkiewicz MJ; Cannon-Albright LA; Teerlink CC; Stevens J; Corcoran C; Gonzalez Murcia JD; Lopez OL; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg G; Kauwe JSK; Lunetta KL; Farrer LA;
JAMA Netw Open; 2019 Mar; 2(3):e191350. PubMed ID: 30924900
[TBL] [Abstract][Full Text] [Related]
10. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
11. Variant of TREM2 associated with the risk of Alzheimer's disease.
Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K
N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908
[TBL] [Abstract][Full Text] [Related]
12. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
13. TREM2 is associated with increased risk for Alzheimer's disease in African Americans.
Jin SC; Carrasquillo MM; Benitez BA; Skorupa T; Carrell D; Patel D; Lincoln S; Krishnan S; Kachadoorian M; Reitz C; Mayeux R; Wingo TS; Lah JJ; Levey AI; Murrell J; Hendrie H; Foroud T; Graff-Radford NR; Goate AM; Cruchaga C; Ertekin-Taner N
Mol Neurodegener; 2015 Apr; 10():19. PubMed ID: 25886450
[TBL] [Abstract][Full Text] [Related]
14. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
16. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
[TBL] [Abstract][Full Text] [Related]
19. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
20. TREM2 p.H157Y Variant and the Risk of Alzheimer's Disease: A Meta-Analysis Involving 14,510 Subjects.
Jiang T; Hou JK; Gao Q; Yu JT; Zhou JS; Zhao HD; Zhang YD
Curr Neurovasc Res; 2016; 13(4):318-320. PubMed ID: 27501831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
